Exosomes – News and Features

This article explores how recent advances in nanoscale technology are helping researchers to obtain more data with less hands-on time, vastly increasing what they can study and discover about diseases.

According to a study, while both diets had equally positive effects on reducing insulin resistance markers, intermittent fasting allowed for stronger improvements in memory and executive function than a standard healthy diet.

Researchers have used small membrane bubbles – which our cells use to communicate – to deliver targeted cancer treatments to tumors in mouse models, demonstrating reduced tumor growth and extended survival in one model.

An estimated 40% of low-back pain cases are attributed to degeneration of the cushiony intervertebral discs that absorb shocks and provide flexibility to the spine.

Now, researchers at University of California San Diego School of Medicine are exploring how to isolate the positive effects of Thiazolidinediones, which could help yield new treatments that don’t come with the old side effects.

Scientists have developed a coin-sized chip that can directly isolate blood plasma from a tube of blood in just 30 minutes, which is more convenient and user-friendly as compared to the current gold standard, multi-step centrifugation process.

A research team has discovered that exosomes derived from γδ-T cells not only have direct anti-tumour effects but also, when developed into a tumour vaccine, can effectively induce a tumour-specific immune response.

Bacteria can be tricked into sending death signals to stop the growth of their slimy, protective homes that lead to deadly infections, a new study demonstrates.

While traditional methods of cell sorting come with several challenges, microbubbles are simple to use and can separate cells without causing harm. Technology Networks spoke to Dr. Brandon McNaughton, CEO and co-founder of Akadeum to find out more about this technology, its applications and how it could improve cancer treatment.

In this interview, John Finn tells us more about PGI, how it compares to other genome editing approaches and the benefits it could bring to genomic medicine discovery.